[Rubella monitoring in Norway].
WHO's "Health for All by the Year 2000" gives as subsidiary objective number 5 "The elimination of measles, poliomyelitis, neonatal tetanus, congenital sequelae of rubella, diphtheria, congenital syphilis and malaria from the European region by the year 2000". This would be attained by a well organized primary care which guarantees effective epidemiological supervision, a vaccination programme with full support, instruction on the risks associated with syphilis, and screening and eventual treatment of pregnant women. It was earlier declared in Norway that congenital rubella should not occur after 1990. Vaccination is carried out; rubella has long been a notifiable disease, and the incidence thereof in females over the age of 15 years is registered in order to ascertain why and how women are nevertheless infected thereby.
Lystad
A
A
Seksjon for forebyggende infeksjonsmedisin, Statens institutt for folkehelse, Oslo.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009664:Norway; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D012409:Rubella / Q000517:prevention & control*; D012410:Rubella Syndrome, Congenital / Q000517:prevention & control; D012411:Rubella Vaccine
D012411:Rubella Vaccine
Rubella-overvåking i Norge.